Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Dancik, Garrett M ^a   Theodorescu, Dan ^b,c,d  

^a EASTERN CONNECTICUT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CELL CYCLE; CELL CYCLE PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; GENE EXPRESSION PROFILING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROSTATE TUMOR; UNIVARIATE ANALYSIS; ADENOCARCINOMA; BLADDER TUMOR; CELL PROLIFERATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

TRANSCRIPTOME; TUMOR MARKER;

ADENOCARCINOMA; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84899889175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085249     Document Type: Article

References (26)

1. Beer DG, Kardia SLR, Huang CC, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine 8: 816-824.
2. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine 346: 1937-1947.
3. van de Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 347: 1999-2009. (Pubitemid 35461656)
4. Diamandis EP (2010) Cancer Biomarkers: Can We Turn Recent Failures into Success? Journal of the National Cancer Institute 102: 1462-1467.
5. Lauss M, Ringner M, Hoglund M (2010) Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study. Clinical cancer research : an official journal of the American Association for Cancer Research 16: 4421-4433.
6. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, et al. (2011) NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic acids research 39: D1005-1010.
7. Dyrskjot L, Zieger K, Real FX, Malats N, Carrato A, et al. (2007) Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clin Cancer Res 13: 3545-3551. (Pubitemid 46955114)
8. Lindgren D, Frigyesi A, Gudjonsson S, Sjodahl G, Hallden C, et al. (2010) Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res 70: 3463-3472.
9. Lee ES, Son DS, Kim SH, Lee J, Jo J, et al. (2008) Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression. Clinical Cancer Research 14: 7397-7404.
10. Colo AE, Simoes AC, Carvalho AL, Melo CM, Fahham L, et al. (2011) Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma. BMC Med Genomics 4: 33.
11. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, et al. (1994) Lymph-Node Prognostic Factors in Head and Neck Squamous-Cell Carcinomas. American Journal of Surgery 168: 494-498. (Pubitemid 24345707)
12. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, et al. (2011) Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics 12: 322.
13. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29. (Pubitemid 30257031)
15. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 28: 27-30. (Pubitemid 30047706)
16. Cuzick J, Berney DM, Fisher G, Mesher D, Moller H, et al. (2012) Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer 106: 1095-1099.
17. Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, et al. (2011) Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol 12: 245-255.
18. Lauss M, Ringner M, Hoglund M (2010) Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study. Clin Cancer Res 16: 4421-4433.
19. Mosley JD, Keri RA (2008) Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics 1: 11.
20. Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S Score A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy. Cancer 117: 5039-5046.
21. Guo Y, Sheng Q, Li J, Ye F, Samuels DC, et al. (2013) Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PloS one 8: e71462.
22. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
23. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expression modules in cancer. Nature Genetics 36: 1090-1098. (Pubitemid 41184471)
24. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E (2011) Smoking and prostate cancer survival and recurrence. JAMA 305: 2548-2555.
25. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, et al. (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11: 4044-4055. (Pubitemid 40791568)
26. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C (2006) Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24: 778-789. (Pubitemid 46622045)